MAP Pharma (MAPP) Misses Q4 Views by 2c
- Wall Street rebounds from Brexit with second day of big gains
- Fed Releases CCAR Results; Objects to Capital Plan of Deutsche Bank (DB), Santander Holdings USA (SC)
- Citigroup (C) Announces Substantial Dividend Hike, $8.6B Stock Buyback Plan Following CCAR Results
- Tractor Supply (TSCO) Prelim. Q2 Results Miss Views; Fy16 Outlook Cut
- Bank of America (BAC) Approves $5B Buyback; Hikes Qtr. Dividend 50%
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q4 loss of $0.46, 2 cents worse than the analyst estimate of ($0.44).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alcoa (AA) Files Initial Form 10 Related to Separation of Upstream Unit
- Pre-Open Stock Movers 06/28: (RLOC) (XNCR) (MRNS) Higher; (RGLS) (BUFF) Lower (more...)
- Achaogen (AKAO) Files 10M Common Stock Shelf for Shareholders
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!